Healthcare -
Biotechnology - NASDAQ - US
$ 3.965
-10.7 %
$ 244 M
Market Cap
-4.22
P/E
GLUE - REVENUE
Revenue GLUE - Monte Rosa Therapeutics, Inc.
75.6 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR